Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs NECTAR LIFESCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS NECTAR LIFESCIENCE IPCA LABS/
NECTAR LIFESCIENCE
 
P/E (TTM) x 51.8 84.0 61.6% View Chart
P/BV x 5.4 0.6 844.5% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 IPCA LABS   NECTAR LIFESCIENCE
EQUITY SHARE DATA
    IPCA LABS
Mar-23
NECTAR LIFESCIENCE
Mar-23
IPCA LABS/
NECTAR LIFESCIENCE
5-Yr Chart
Click to enlarge
High Rs1,06234 3,113.9%   
Low Rs76814 5,348.2%   
Sales per share (Unadj.) Rs243.058.0 418.9%  
Earnings per share (Unadj.) Rs19.4-1.1 -1,798.1%  
Cash flow per share (Unadj.) Rs29.71.6 1,906.5%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs230.347.5 485.1%  
Shares outstanding (eoy) m253.70224.26 113.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.80.4 901.4%   
Avg P/E ratio x47.2-22.5 -210.0%  
P/CF ratio (eoy) x30.815.6 198.1%  
Price / Book Value ratio x4.00.5 778.4%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m232,1205,434 4,271.8%   
No. of employees `000NANA-   
Total wages/salary Rs m12,876751 1,713.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64213,008 473.9%  
Other income Rs m1,518432 351.5%   
Total revenues Rs m63,16013,440 470.0%   
Gross profit Rs m9,033530 1,704.1%  
Depreciation Rs m2,616591 442.4%   
Interest Rs m482795 60.6%   
Profit before tax Rs m7,453-424 -1,756.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534-182 -1,389.3%   
Profit after tax Rs m4,919-242 -2,034.2%  
Gross profit margin %14.74.1 359.6%  
Effective tax rate %34.043.0 79.1%   
Net profit margin %8.0-1.9 -429.3%  
BALANCE SHEET DATA
Current assets Rs m51,89312,312 421.5%   
Current liabilities Rs m18,0588,909 202.7%   
Net working cap to sales %54.926.2 209.8%  
Current ratio x2.91.4 207.9%  
Inventory Days Days5156 92.2%  
Debtors Days Days678 7.5%  
Net fixed assets Rs m34,3369,375 366.3%   
Share capital Rs m254224 113.1%   
"Free" reserves Rs m58,16710,422 558.1%   
Net worth Rs m58,42010,646 548.8%   
Long term debt Rs m6,5182,265 287.8%   
Total assets Rs m86,22921,686 397.6%  
Interest coverage x16.50.5 3,530.9%   
Debt to equity ratio x0.10.2 52.4%  
Sales to assets ratio x0.70.6 119.2%   
Return on assets %6.32.6 245.6%  
Return on equity %8.4-2.3 -370.7%  
Return on capital %12.22.9 425.6%  
Exports to sales %42.962.0 69.2%   
Imports to sales %13.346.2 28.7%   
Exports (fob) Rs m26,4348,064 327.8%   
Imports (cif) Rs m8,1786,012 136.0%   
Fx inflow Rs m26,4348,064 327.8%   
Fx outflow Rs m8,1786,121 133.6%   
Net fx Rs m18,2571,942 939.9%   
CASH FLOW
From Operations Rs m8,0581,337 602.9%  
From Investments Rs m-7,250517 -1,402.2%  
From Financial Activity Rs m5,072-1,856 -273.3%  
Net Cashflow Rs m5,881-2 -257,916.7%  

Share Holding

Indian Promoters % 46.3 55.8 83.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 16.1 277.7%  
FIIs % 10.3 16.1 63.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 44.2 121.5%  
Shareholders   82,809 60,761 136.3%  
Pledged promoter(s) holding % 0.0 100.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs NECTAR LIFESCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs NECTAR LIFESCIENCE Share Price Performance

Period IPCA Labs NECTAR LIFESCIENCE S&P BSE HEALTHCARE
1-Day 3.43% 0.67% 1.30%
1-Month 4.35% -18.92% -0.64%
1-Year 56.61% 107.19% 62.01%
3-Year CAGR 9.49% 16.67% 18.20%
5-Year CAGR 20.90% 12.28% 19.81%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the NECTAR LIFESCIENCE share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of NECTAR LIFESCIENCE the stake stands at 55.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of NECTAR LIFESCIENCE.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

NECTAR LIFESCIENCE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of NECTAR LIFESCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.